SCHEMBL8482013

SCHEMBL8482013

[CH](c1cccnc1)C1CCNCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.43
CHRNA4 P43681 6/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP11B1 P15538 1/20 0.43
CYP11B2 P19099 1/20 0.43
KDM1A O60341 1/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
JUN P05412 1/20 0.42
NFKB1 P19838 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
CHRNB4 P30926 3/20 0.41
CHRNA3 P32297 3/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
CHRNA7 P36544 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9534693 0.84 CYP11B2 (0.47) CHRNB2CHRNA4ALDH1A1CYP11B1CYP11B2
SCHEMBL8911537 0.82 ALDH1A1 (0.51) CHRNB2CHRNA4ALDH1A1CYP11B1CYP11B2
SCHEMBL8481040 0.78 AKT1 (0.39) CHRNB2CHRNA4ALDH1A1MAPTKDM4E
SCHEMBL22193951 0.78 CYP11B1 (0.46) CHRNB2CHRNA4CYP11B1CYP11B2MAPT
SCHEMBL3168277 0.78 CYP11B1 (0.46) CHRNB2CHRNA4CYP11B1CYP11B2MAPT
SCHEMBL9970115 0.78 CYP11B1 (0.46) CHRNB2CHRNA4CYP11B1CYP11B2MAPT
SCHEMBL6002937 0.77 SLC18A3 (0.48) KDM1A
SCHEMBL5133115 0.73 CHRNB2 (0.53) CHRNB2CHRNA4ALDH1A1CYP11B1CYP11B2
SCHEMBL28185019 0.71 CHRNB2 (0.42) CHRNB2CHRNA4KDM1ACHRNB4CHRNA3
SCHEMBL8074183 0.71 SLC18A3 (0.41) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed